ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma

Cancer

Volumn 77, Issue 1, 1996, Pages 71-78

  Onda, Masanori ^a,b   Matsuda, Satoru ^a   Higaki, Shozo ^c   Iijima, Takuo ^b   Fukushima, Jun Ichi ^b   Yokokura, Akira ^b   Kojima, Tatsuyoshi ^b   Horiuchi, Hajime ^b   Kurokawa, Takahide ^b   Yamamoto, Tadashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

Author keywords

ErbB 2; osteosarcoma; prognosis; protein tyrosine kinase

Indexed keywords

DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LUNG METASTASIS; MALE; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTO ONCOGENE; SCHOOL CHILD; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; BLOTTING, SOUTHERN; BONE NEOPLASMS; CHILD; DNA, SINGLE-STRANDED; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; PROGNOSIS; RECEPTOR, ERBB-2; SURVIVAL ANALYSIS;

EID: 13344285355     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960101)77:1<71::AID-CNCR13>3.0.CO;2-5     Document Type: Article

References (51)

1. Campanacci M. Bone and soft tissue tumors. New York: Springer-Verlag, 1990:455-505.
2. Ikeda S, Sumii H, Akiyama K, Watanabe S, Ito S, Inoue H, et al. Amplification of both c-myc and c-raf-1 oncogenes in a human osteosarcoma. Jpn J Cancer Res 1989;80:6-9.
3. Yokota J, Yokota YT, Battifora H, Fevre CL, Cline MJ. Alteration of myc, myb, and H-ras proto-oncogenes in cancers are frequent and show clinical correlation. Science 1986;231:261-5.
4. Bogenmann E, Moghadam H, DeClerck YA, Mock A. c-myc Amplification and expression in newly established human osteosarcoma cell lines. Cancer Res 1987;47:3808-14.
5. Roberts WM, Douglass EC, Peiper SC, Houghton PJ, Look AT. Amplification of the gli gene in childhood sarcoma. Cancer Res 1989;49:5407-13.
6. Graves DT, Owen AJ, Barth RK, Tempst P, Winoto A, Fors L, et al. Detection of c-sis transcripts and synthesis of PDGF-like proteins by human osteosarcoma cells. Science 1984;226:972-4.
7. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323:643-6.
8. Miller C, Aslo A, Tsay C, Slamon D, Ishizaki K, Toguchida J, et al. Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res 1990;50:7950-4.
9. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992;358:80-3.
10. Ladanyi M, Cha C, Lewis R, Jhanwar SC, Huvos AG, Healey JH. MDM2 gene amplification in metastatic osteosarcoma. Cancer Res 1993;53:16-8.
11. Fukushige S, Matsubara K, Yoshida M, Sasaki M, Suzuki T, Semba K, et al. Localization of a novel v-erbB-related gene, c-erbB-2 on human chromosome-17 and its amplification in a gastric cancer cell line. Mol Cell Biol 1986;6:955-8.
12. Coussens L, Yang-Feng TL, Liao Y, Chen E, Gray A, McGrath J, et al. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 1985;230:1132-9.
13. Bargmann CI, Hung MC, Weinberg RA. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 1986;319:226-30.
14. Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, et al. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor. Nature 1986;319:230-4.
15. Akiyama T, Sudo C, Ogawara H, Toyoshima K, Yamamoto T. The product of human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 1986;232:1644-6.
16. Peles E, Bacus SS, Kosuki RA, Lu HS, Wen D, Ogden SG, et al. Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells. Cell 1992;69:205-16.
17. Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, et al. Identification of heregulin, a specific activator of p185. Science 1992;256:1205-10.
18. Peles E, Ben-Levy R, Tzahar E, Liu N, Wen D, Yarden Y. Cell-type specific interaction of neu differentiation factor (NDF/ heregulin) with neu/HER-2 suggests complex ligand-receptor relationships. EMBO J 1993;12:961-71.
19. Bargmann CI, Hung MC, Weinberg RA. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 1986;54:649-57.
20. Di Fiore DP, Pierce JH, Fleming TP, Hazan R, Ullrich A, King CC, et al. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell 1987;51:1063-70.
21. Hudziak RM, Schlessinger J, Ullrich A. Increased expression of the putative growth factor receptor p185 causes transformation and tumorigenesis of NIH 3T3 cells. Proc Natl Acad Sci USA 1987;84:7159-63.
22. Slamon DJ, Clark GM, Wong SG, Lewin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235:177-82.
23. Van De Viver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dilesio O, et al. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Eng J Med 1988;319:1239-45.
24. Venter DJ, Tuzi NI, Kumar S, Gullick WJ. Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification. Lancet 1987;2:69-72.
25. Barnes DM, Lammie GA, Millis RR, Gullick WL, Allen DS, Altman DG. An immunohistochemical evaluation of c-erbB-2 expression in human carcinoma. Br J Cancer 1988;58:448-52.
26. Wright C, Angus B, Nicholson S, Sainsbury RC, Cairns J, Gullick WJ, et al. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res 1989;49:2087-90.
27. Semba K, Kamata N, Toyoshima K, Yamamoto T. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc Natl Acad Sci USA 1985;82:6497-501.
28. Dujin Z, Hector B, Yokota J, Yamamoto T, Martin JC. Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer. Cancer Res 1987;47:6123-5.
29. Press MF, Cordon-Cardo C, Slamon DJ. Expression of the HER-2/neu protooncogene in normal human adult and fetal tissues. Oncogene 1990;5:953-62.
30. Enneking WF, Spaner SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 1980;153:44-6.
31. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
32. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
33. Yamashita H, Kobayashi S, Iwase H, Itoh Y, Kuzushima T, Iwata H, et al. Analysis of oncogenes and tumor suppressor genes in human breast cancer. Jpn J Cancer Res 1993;84:871-8.
34. Nick RL, Susan S, Clive D, Diana MB, William JG. Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer. Oncogene 1990;5:237-9.
35. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
36. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
37. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, et al. Studies of HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989;244:707-12.
38. Yokota J, Yamamoto T, Toyoshima K, Terada M, Sugimura T, Battifora H, et al. Amplification of c-erbB-2 oncogene in human adenocarcinomas in vitro. Lancet 1986;1:765-7.
39. Tal M, Wetzler M, Josefberg Z, Deuten A, Gutman M, Assaf D, et al. Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues. Cancer Res 1988;48:1517-20.
40. Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacayjo A, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982;49:1221-30.
41. Masuda H, Miller C, Koeffler H, Battifora H, Cline M. Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci USA 1987;84:7716-9.
42. Toguchida J, Yamaguchi T, Ritchie B, Beauchamp R, Dayton S, Herrera G, et al. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 1992;52:6194-9.
43. Ueda Y, Dockhorn-Dworniczak B, Blasius S, Mellin W, Wuisman P, Bocker W, et al. Analysis of mutant p53 protein in osteosarcomas and other malignant and benign lesions of bone. J Cancer Res Clin Oncol 1993;119:172-8.
44. Bargmann CI, Weinberg RA. Oncogenic activation of the new-encoded receptor protein by point mutation and deletion. EMBO J 1988;7:2043-52.
45. Bargmann CI, Weinberg RA. Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene. Proc Natl Acad Sci USA 1988;85:5394-8.
46. Stem DF, Kamps MP, Cao H. Oncogenic activation of p185 stimulates tyrosine phosphorylation in vivo. Mol Cell Biol 1988;8:3969-73.
47. Segatto O, King CR, Pierce JH, Di Fiore PP, Aaronson SA. Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene. Mol Cell Biol 1988;8:5570-4.
48. Etienne MC, Fischel JL, Milano G, Formento P, Francoual M, Frenay M, et al. Steroid receptors in human osteoblast-like cells. Eur J Cancer 1990;26:807-10.
49. Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegos A, Kore M, et al. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 1988;241:81-4.
50. Ernst M, Schmid C, Froesch ER. Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc Natl Acad Sci USA 1988;85:2307-10.
51. Matsuda S, Kadowaki Y, Ichino M, Akiyama T, Toyoshima K, Yamamoto T. 17β-Estradiol mimics ligand activity of the c-erbB-2 protooncogene product. Proc Natl Acad Sci USA 1993;90:10803-7.